Medicare Enrolled

Dr. Ramon Rodriguez-Cruz, MD

Neurology · Orlando, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Speaking/Promotional
92 N DEAN RD, Orlando, FL 32825
4079160304
In practice since 2006 (19 years)
NPI: 1255377099 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Rodriguez-Cruz from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Rodriguez-Cruz? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Rodriguez-Cruz

Dr. Ramon Rodriguez-Cruz is a neurology in Orlando, FL, with 19 years in practice. Based on federal Medicare data, Dr. Rodriguez-Cruz performed 40,083 Medicare services across 2,191 unique beneficiaries.

Between the years covered by Open Payments, Dr. Rodriguez-Cruz received a total of $973,008 from 61 pharmaceutical and/or device companies across 1894 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Rodriguez-Cruz is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice▲ Top 2% volume in FL$ $973,008 industry payments

Medicare Practice Summary

Medicare Utilization ↗
40,083
Medicare services
Top 2% in FL for neurology
2,191
Unique beneficiaries
$15
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~2,110 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Botox injection, per unit34,710$5$9
Office visit, established patient (30-39 min)1,460$92$163
Injection, rimabotulinumtoxinb, 100 units1,101$9$18
Principal care management services for a single high-risk disease, first 30 minutes provided personally by qualified health care professional, per calendar month.842$60$125
Evaluation of neuropsychological test, first hour247$98$201
Administration of psychological or neuropsychological test by technician, first 30 minutes246$25$55
Office visit, established patient, complex (40-54 min)213$136$219
EEG, extended monitoring200$327$631
Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle159$58$115
New patient office visit, complex (60-74 min)146$151$313
Injection of chemical for paralysis of nerve muscles on side of neck excluding voice box102$163$271
Electronic analysis of implanted brain, spinal cord, or peripheral neurostimulator generator86$14$50
Assessment of and care planning for patient with impaired thought processing, typically 60 minutes81$204$389
Advance care planning consultation, first 30 min70$65$124
Injection of chemical for paralysis of nerve muscles on side of face69$134$248
Electronic analysis of implanted brain, spinal cord, or peripheral neurostimulator generator with brain stimulator programming, each additional 15 minutes with qualified health professional66$34$70
Exam of neurobehavioral status, first hour54$73$145
Electronic analysis of implanted brain, spinal cord, or peripheral neurostimulator generator with brain stimulator programming, first 15 minutes with qualified health professional42$37$79
Telephone medical discussion with physician, 21-30 minutes38$95$195
Injection of chemical for paralysis of nerve muscles on arm or leg, 1-4 muscles, first extremity37$102$227
New patient office visit (45-59 min)35$123$248
Injection of chemical for paralysis of salivary glands on both sides of mouth34$98$188
Office visit, established patient (20-29 min)18$66$112
Telephone medical discussion with physician, 11-20 minutes14$70$100
Administration of psychological or neuropsychological test by technician, each additional 30 minutes13$26$50
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$973,008
Total received (2018-2024)
Avg $139,001/year across 7 years
Top 1% in FL for neurology
61
Companies
1,894
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$860,043 (88.4%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$104,087 (10.7%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,878 (0.9%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$157,285
2023
$195,531
2022
$177,129
2021
$89,853
2020
$78,787
2019
$158,471
2018
$115,952

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Neurocrine Biosciences, Inc.
$154,642
Acorda Therapeutics, Inc
$144,325
Teva Pharmaceuticals USA, Inc.
$129,457
ABBVIE INC.
$77,254
Eisai Inc.
$70,681
Adamas Pharmaceuticals, Inc.
$70,386
AbbVie Inc.
$43,294
Sunovion Pharmaceuticals Inc.
$42,297
AbbVie, Inc.
$41,103
Neurocrine BioSciences, Inc.
$38,160
Amneal Pharmaceuticals LLC
$29,711
Allergan, Inc.
$27,263
MDD US Operations, LLC
$22,869
Kyowa Kirin, Inc.
$16,666
Boston Scientific Corporation
$16,253
MITSUBISHI TANABE PHARMA AMERICA, INC.
$12,072
ACADIA Pharmaceuticals Inc
$9,165
Abbott Laboratories
$6,561
Avion Pharmaceuticals
$6,184
Genentech, Inc.
$4,770
BOSTON SCIENTIFIC CORPORATION
$3,191
Lilly USA, LLC
$751
Allergan Inc.
$416
Amgen Inc.
$410
Biohaven Pharmaceutical Holding Company Ltd.
$377
ARGENX US, INC.
$371
Biogen, Inc.
$357
PFIZER INC.
$336
US WorldMeds, LLC
$329
Saol Therapeutics Inc.
$300
Biohaven Pharmaceuticals, Inc.
$286
Supernus Pharmaceuticals, Inc.
$249
EMD Serono, Inc.
$246
Merz Pharmaceuticals, LLC
$222
GE HEALTHCARE
$204
Otsuka America Pharmaceutical, Inc.
$199
CSL Behring
$178
GE HealthCare
$139
UCB, Inc.
$138
IDORSIA PHARMACEUTICALS US INC
$122
GRT US Holding, Inc.
$117
Grifols USA, LLC
$93
Lundbeck LLC
$88
Currax Pharmaceuticals LLC
$82
Dynasplint Systems Inc.
$76
Neuronetics, Inc.
$68
Corium, LLC
$64
Takeda Pharmaceuticals U.S.A., Inc.
$61
Alnylam Pharmaceuticals Inc.
$55
Novartis Pharmaceuticals Corporation
$53
LivaNova USA, Inc.
$48
Cala Health, Inc.
$45
Vertical Pharmaceuticals, LLC
$37
Genentech USA, Inc.
$28
Alexion Pharmaceuticals, Inc.
$27
Medtronic, Inc.
$25
Merz North America, Inc.
$24
Hoffmann-La Roche Limited
$24
CATALYST PHARMACEUTICALS, INC.
$21
SCILEX PHARMACEUTICALS INC.
$19
REVANCE THERAPEUTICS, INC.
$15
Top 3 companies account for 44.0% of total payments
Associated products mentioned in payments ›
ADLARITY · ADUHELM · AIMOVIG · AJOVY · AMYVID · APOKYN · APTIOM · AUSTEDO · AVONEX · Adlarity · Aimovig · Austedo XR · BOTOX · CALA TRIO · COMIRNATY · CONFIRM RX · CONTRAVE · COPAXONE · CREXONT · DAXXIFY · DUOPA · Dhivy · Duopa · Dynasplint · EMGALITY · ETERNA · Evrysdi · FIRDAPSE · GENERAL DBS · GENERAL DBS · GENERAL THERAPIES · GENERAL - DBS · GOCOVRI · Gamunex-C · General - DBS · Gocovri · HYQVIA · Hizentra · INBRIJA · INFINITY · INGREZZA · Infinity DBS Pulse Generators · IonicRF Generator · KISUNLA · KYNMOBI · Kcentra · LATUDA · Leqembi · Lioresal Intrathecal (baclofen injection) · MAVENCLAD · MYOBLOC · NEUROSTAR TMS THERAPY · NORTHERA · NOURIANZ · NUPLAZID · NURTEC ODT · Nayzilam · Nourianz · ONGENTYS · ONGENTYS 50MG CAPSULES 30 · ONPATTRO · ONZETRA XSAIL · OSMOLEX ER · Ongentys · PAXLOVID · PERCEPT PC BRAINSENSE · Proclaim IPG · QULIPTA · QUVIVIQ · Qutenza · RADICAVA · RELEXXII · REXULTI · RYTARY · Rystiggo · SKYCLARYS · SPECTRA WAVEWRITER · SPINRAZA · TECFIDERA · TYSABRI · UBRELVY · ULTOMIRIS · VERCISE · VNS Therapy · VUMERITY · VYALEV · VYEPTI · VYVGART · VYVGART HYTRULO · XEOMIN · Xadago · Xeomin · ZTLido
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (88%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in neurology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 1% for neurology in FL.

Equivalent to $2,427 per 100 Medicare services performed
Looking for a neurology in Orlando?
Compare neurologys in the Orlando area by procedure volume, costs, and industry payment transparency.
Browse neurologys nearby

Geographic Context

Neurologys within 10 mi
87
Per 100K population
6.0
County median income
$77,011
Nearest hospital
UNIVERSITY BEHAVIORAL CENTER
4.4 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Rodriguez-Cruz is a mixed practice specialist, with above-average Medicare volume (top 2% in FL), and high industry engagement (speaking/promotional, top 1%), with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Rodriguez-Cruz experienced with botox injection, per unit?
Based on Medicare claims data, Dr. Rodriguez-Cruz performed 34,710 botox injection, per unit services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Rodriguez-Cruz receive payments from pharmaceutical companies?
Yes. Dr. Rodriguez-Cruz received a total of $973,008 from 61 companies across 1,894 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Rodriguez-Cruz's costs compare to other neurologys in Orlando?
Dr. Rodriguez-Cruz's average Medicare payment per service is $15. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Rodriguez-Cruz) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →